Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-20-015193
Filing Date
2020-06-17
Accepted
2020-06-17 16:11:42
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO REGISTRATION STATEMENT ea123042-s1a6_aditxtherape.htm S-1/A 79560
2 FORMOF UNDERWRITING AGREEMENT ea123042ex1-1_aditxtherape.htm EX-1.1 234628
3 FORM OF WARRANT AGENT AGREEMENT ea123042ex4-2_aditxtherape.htm EX-4.2 118817
4 FORMOF UNDERWRITER'S UNIT PURCHASE AGREEMENT ea123042ex4-3_aditxtherape.htm EX-4.3 58889
5 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP ea123042ex5-1_aditxtherape.htm EX-5.1 14317
6 GRAPHIC image_001.jpg GRAPHIC 10297
  Complete submission text file 0001213900-20-015193.txt   521528
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-235933 | Film No.: 20969840
SIC: 2834 Pharmaceutical Preparations